IFNG and neoplasm: Other epigenetic mechanisms associated with clinically beneficial responses to ICIs include disruption of the SWI/SNF complex, a chromatin remodeler, enhancing secretion of effector T-cell-attracting chemokines through increased tumor sensitivity to IFN-γ [96].